Abbott Laboratories Data Engineer Salary by Level

The thinnest part of this picture is at the extremes. 4 engineers reported at staff level, which makes the $207K median real but sensitive to a single outlier offer; the 16 senior reports and 22 mid-level reports carry proportionally more weight and deserve more trust. The pool draws from both verified individual offers and base-only public filings whose total comp figures are modeled from peer ratios, so a report without a bonus or equity component visible in the source is estimated up, not omitted. All 42 reports in the pool are DE-scoped, not blended with software engineers or analysts, which matters at a company where those roles pay differently. The most recent data reflects offers through Aug 2, 2026; at a company that hires carefully and in small volume, a single recent cohort can move a level median noticeably.

Abbott structures data engineer compensation conservatively, leaning on base salary rather than equity as the primary total comp driver. Healthcare device companies at Abbott's scale rarely offer the RSU-heavy packages that define pay at cloud or consumer tech firms; the equity component, where it exists, tends to be smaller grants with standard 4-year vesting rather than the front-loaded refresh cycles common in hyperscalers. Bonus eligibility is standard for the industry, typically a target percentage of base tied to company and individual performance, but verified reports suggest the bonus layer adds less to total comp than the base figure alone implies. What this means practically: the headline number for a senior or staff offer at Abbott is closer to realized annual cash than an equivalent headline at an equity-heavy employer, where vesting cliffs and refresh timing can spread the actual value across years.

Abbott's pay landing slightly above other Healthcare companies reflects a deliberate positioning choice for a company in regulated healthcare rather than competitive pressure to match tech. The likeliest driver is that Abbott recruits from a different talent pool than a pure-play tech firm: engineers with domain fluency in medical device data, FDA pipeline requirements, and clinical trial data handling are not uniformly recruited by the companies that set the high end of the DE market. That narrower competition for a specific profile lets Abbott pay a modest premium over healthcare peers without chasing the broader tech salary floor. The 3-level ladder also plays a role: a compressed progression means the company concentrates headcount at mid and senior rather than building out staff and principal bands that would push median comp higher across the pool. The premium is real but bounded.

The most consequential choice going into an Abbott offer is whether to negotiate toward L6 rather than accepting a 16-report senior placement. The gap between $154K and $207K is the largest single move available on this ladder, and with only 3 levels total, there is no principal or distinguished tier to reach later. Base salary is the primary flex point: Abbott's equity component is modest enough that negotiating on RSU quantity produces less realized impact than a base adjustment of a few thousand dollars compounded over the vesting window. A competing offer from another healthcare employer matters more than a tech offer when making your case, because recruiters can benchmark against peers but will often decline to match a number they see as coming from a structurally different pay market. If you are holding an offer at senior, the single highest-value move is to document scope that maps to staff expectations and request a level review before signing.